Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality

Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality

Kevin Outterson and colleagues outline a model to address access, conservation, and innovation of antibiotics.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature methods 2016-06, Vol.13 (6), p.e1002043-e1002043
Hauptverfasser: Outterson, Kevin, Gopinathan, Unni, Clift, Charles, So, Anthony D, Morel, Chantal M, Røttingen, John-Arne
Format: Artikel
Sprache:eng
Schlagworte:
Anti-Bacterial Agents
Antibiotics
Antimicrobial agents
Biology and Life Sciences
Business models
Collaboration
Commerce - economics
Drug Industry - economics
Drug resistance
Economic development
Finance
Funding
GDP
Gross Domestic Product
Incentives
Innovations
Investments
Medicine and Health Sciences
Models, Theoretical
Pharmaceutical research
Pharmaceutical Research - economics
R&D
Research & development
Sales
Social Sciences
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Kevin Outterson and colleagues outline a model to address access, conservation, and innovation of antibiotics.
ISSN:1549-1676
1549-1277
1548-7091
1549-1676
1548-7105
DOI:10.1371/journal.pmed.1002043